Trade

with

Globus Medical Inc
(NYSE: GMED)
AdChoices
19.98
+0.02
+0.10%
After Hours :
19.98
0.00
0.00%

Open

20.00

Previous Close

19.96

Volume (Avg)

589.07k (680.75k)

Day's Range

19.86-20.32

52Wk Range

17.45-27.14

Market Cap.

1.89B

Dividend Rate ( Yield )

-

Beta

-0.12

Shares Outstanding

-

P/E Ratio (EPS)

22.83 (0.87)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 434.46M

    • Net Income

    • 68.61M

    • Market Cap.

    • 1.89B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 18.45

    • PEG (Price/Earnings Growth) Ratio

    • 1.84

    • Beta

    • -0.12

    • Forward P/E

    • 19.92

    • Price/Sales

    • 4.21

    • Price/Book Value

    • 3.57

    • Price/Cash flow

    • 17.57

      • EBITDA

      • 121.07M

      • Return on Capital %

      • 14.89

      • Return on Equity %

      • 17.48

      • Return on Assets %

      • 14.89

      • Book Value/Share

      • 5.60

      • Shares Outstanding

      • -

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Buy
        • 1 Year Price Target

        • 24.00

        • Credit Rating

        • -

        • Analysts

        • 3

        • EPS Estimate

        • 1.00

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 6.10

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -7.10

          • -22.64

          • Net Income

            Q/Q (last year)

          • 178.00

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 76.90

            • 64.08

            • Pre-Tax Margin

            • 27.96

            • 15.19

            • Net Profit Margin

            • 18.45

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.34

              • Current Ratio

              • 7.08

              • 2.55

              • Quick Ratio

              • 5.24

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.17

              • 1.86

              • Book Value/Share

              • 5.60

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 22.83

                • 34.01

                • P/E Ratio 5-Year High

                • 31.02

                • 224.03

                • P/E Ratio 5-Year Low

                • 11.73

                • 60.23

                • Price/Sales Ratio

                • 4.21

                • 3.17

                • Price/Book Value

                • 3.57

                • 3.20

                • Price/Cash Flow Ratio

                • 17.57

                • 18.42

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 17.48

                        (-)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • 14.89

                        (-)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • 17.48

                        (-)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • 97.74k

                      • 34.11k

                      • Inventory Turnover

                      • 1.41

                      • 2.77

                      • Asset Turnover

                      • 0.81

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      101.67M
                      Operating Margin
                      23.40
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      17.57
                      Ownership

                      Institutional Ownership

                      57.74%

                      Top 10 Institutions

                      23.57%

                      Mutual Fund Ownership

                      28.31%

                      Float

                      97.90%

                      5% / Insider Ownership

                      1.26%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Vanguard Explorer Fund

                      •  

                        2,487,533

                      • -6.51

                      • 2.64

                      • Oak Ridge Small Cap Growth Fund

                      •  

                        1,732,639

                      • 0.00

                      • 1.84

                      • Champlain - Small Cap Equity

                      •  

                        1,713,700

                      • 16.25

                      • 1.82

                      • Vanguard Small Cap Index

                      •  

                        1,224,396

                      • 4.53

                      • 1.30

                      • Vanguard Total Stock Mkt Idx

                      •  

                        1,137,249

                      • 4.73

                      • 1.21

                      • iShares Russell 2000 (AU)

                      •  

                        1,022,757

                      • -1.01

                      • 1.10

                      • Vanguard Small Cap Growth Index Fund

                      •  

                        827,525

                      • 2.60

                      • 0.88

                      • Lord Abbett Developing Growth Fund

                      •  

                        735,755

                      • -45.48

                      • 0.78

                      • Champlain Small Company Fund

                      •  

                        700,000

                      • 38.61

                      • 0.74

                      • Vanguard Extended Market Index Fund

                      •  

                        602,813

                      • 17.49

                      • 0.64

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Wellington Management Company, LLP

                      •  

                        5,295,599

                      • -7.87%

                      • 5.61

                      • Vanguard Group, Inc.

                      •  

                        3,927,043

                      • +6.30%

                      • 4.16

                      • Oak Ridge Investments, LLC

                      •  

                        2,671,966

                      • +0.68%

                      • 2.83

                      • Champlain Investment Partners, LLC

                      •  

                        1,843,325

                      • +16.13%

                      • 1.95

                      • BlackRock Fund Advisors

                      •  

                        1,649,690

                      • +8.13%

                      • 1.75

                      • Gannett Welsh & Kotler, LLC

                      •  

                        1,606,121

                      • +23.86%

                      • 1.70

                      • Cortina Asset Management LLC

                      •  

                        1,411,975

                      • -1.92%

                      • 1.50

                      • Century Capital Management, LLC

                      •  

                        1,353,003

                      • -6.30%

                      • 1.43

                      • OppenheimerFunds, Inc.

                      •  

                        1,334,230

                      • +51.90%

                      • 1.41

                      • Invesco Advisers, Inc

                      •  

                        1,159,985

                      • +16.85%

                      • 1.23

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Classic Growth

                      Style

                      Small Core

                      Globus Medical Inc was incorporated in Delaware in March 3, 2003. The Company is a medical device company focused exclusively on the design, development and commercialization of musculoskeletal implants. It is currently focused on im...moreplants that promote healing in patients with spine disorders. All of its products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company’s Innovative Fusion products address a spinal fusion surgical procedures. Spinal fusion is a surgical procedure to correct problems with the individual vertebrae, the interlocking bones making up the spine, by preventing movement of the affected bones. It currently offers over 120 products for the treatment of spine disorders. Products in Innovative Fusion includes: CREO, a convenient non-threaded loc...moreking cap design that eases building of thoracolumbar fixation constructs to readily adapt to the patient’s anatomy and condition, for a range of clinical applications. XPAND, FORTIFY, FORTIFY-I corpectomy devices that incorporate smooth expansion capability, have a range of size options for optimal fit, and are manufactured from titanium or radiolucent polyetheretherketone. COALITION and INDEPENDENCE stand-alone interbody fusion devices, simplify the surgical technique by reducing steps and hardware while providing confident stabilization. Disruptive Technologies represent a shift in the treatment of spine disorders by allowing for novel surgical procedures, improvements to existing surgical procedures, and the treatment of spine disorders by new physician specialties, and surgical intervention earlier in the continuum of care. Products in Disruptive Technologies includes: MIS products which enable a surgeon to perform a procedure less invasively to minimize tissue disruption and maximize native anatomy, for patient recovery and fewer approach-related complications. For example, MARS 3V retractor system facilitates smaller incisions with the use of positionable radiolucent retractor blades to access the surgical site and to allow both direct and radiographic visualization. CALIBER, RISE and recently launched LATIS expandable interbody spacers are designed for reliable, minimally disruptive delivery through small MIS incisions with streamlined implants and instruments. REVOLVE pedicle screw system is designed for MIS screw and rod insertion through small incisions, and utilizes a convenient non-threaded locking cap design. TRANSITION, provide for stabilization that is less rigid than traditional pedicle screw systems for more natural load distribution to help promote fusion while maintaining stability. Other products included are SECURE-C, SECURE-CR, KINEX, MICROFUSE, SHIELD, AFFIRM, among others. Company’s competitors include: Medtronic, the DePuy Synthes Companies, Stryker and NuVasive. Alphatec Spine, Orthofix International, Zimmer, LDR, among others. As of December 31, 2013, the Company owned 188 issued U.S. patents and had applications pending for 322 U.S. patents, and owned 70 issued foreign patents and had applications pending for 131 foreign patents. Its business is subject to extensive federal, state, local and foreign regulations. Its products are medical devices and tissues subject to extensive regulation by the FDA and other federal, state, local and foreign regulatory bodies.lessless

                      Key People

                      Mr. David C. Paul

                      CEO/Chairman of the Board/Director/Founder

                      David D. Davidar

                      Director/Founder/Vice President, Divisional

                      Richard A. Baron

                      Senior VP/CFO

                      A. Bret Murphy

                      Executive VP, Divisional

                      Kurt C. Wheeler

                      Director

                      • Globus Medical Inc

                      • 2560 General Armistead Avenue

                      • Audubon, PA 19403

                      • USA.Map

                      • Phone: +1 610 930-1800

                      • Fax: +1 610 930-2042

                      • globusmedical.com

                      Incorporated

                      2003

                      Employees

                      850

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: